Evaluation of the Long-term Efficacy and Safety of Monofocal Plate Haptic Intraocular Lens

NCT06238271 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2024-02-02

No results posted yet for this study

Summary

Our study aims to determine the efficacy and safety of the monofocal plate haptic intraocular lens to be implanted in patients planning for cataract surgery and to determine the complications that may develop due to the lens.

Conditions

  • Lens Implantation, Intraocular
  • Cataract

Interventions

DEVICE

Acriva BB UDM 611

Acriva BB UDM 611 intraocular lens will be implanted into the capsular bag in patients who undergo cataract extraction with phacoemulsification.

Sponsors & Collaborators

  • VSY Biotechnology

    collaborator UNKNOWN
  • Yuzuncu Yıl University

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-23
Primary Completion
2024-11-30
Completion
2025-05-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06238271 on ClinicalTrials.gov